Ridgewood NJ, Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed.
The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.
The new saliva collection method, which RUCDR developed in partnership with Spectrum Solutions and Accurate Diagnostic Labs (ADL), will allow for broader population screening than the current method of nose and throat swabs.
Warning: Undefined array key "sfsi_riaIcon_order" in /home/eagle1522/public_html/theridgewoodblog.net/wp-content/plugins/ultimate-social-media-icons/libs/controllers/sfsi_frontpopUp.php on line 165
Warning: Undefined array key "sfsi_inhaIcon_order" in /home/eagle1522/public_html/theridgewoodblog.net/wp-content/plugins/ultimate-social-media-icons/libs/controllers/sfsi_frontpopUp.php on line 166
Warning: Undefined array key "sfsi_mastodonIcon_order" in /home/eagle1522/public_html/theridgewoodblog.net/wp-content/plugins/ultimate-social-media-icons/libs/controllers/sfsi_frontpopUp.php on line 177